LAUREN BARBOSA: Open Payments
NPI 1851926257 · QUINCY, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$882 in 31 payments from 9 companies in 2025. Trend: 2023 $1,006 · 2024 $1,040 · 2025 $882
Food & beverage: $882
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 10 | $237 |
| Janssen Biotech, Inc. | 8 | $227 |
| ABBVIE INC. | 6 | $203 |
| GENZYME CORPORATION | 1 | $105 |
| Galderma Laboratories, L.P. | 2 | $36 |
| PFIZER INC. | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Arcutis Biotherapeutics, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $15 |
Products named: OPZELURA, TREMFYA, SKYRIZI, DUPIXENT, CIBINQO, RINVOQ, NEMLUVIO, Sotyktu.
Industry payments across MA — which companies pay providers there.
